Cargando…

Molecular and cellular immune features of aged patients with severe COVID-19 pneumonia

Aging is a major risk factor for developing severe COVID-19, but few detailed data are available concerning immunological changes after infection in aged individuals. Here we describe main immune characteristics in 31 patients with severe SARS-CoV-2 infection who were >70 years old, compared to 3...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lo Tartaro, Domenico, Neroni, Anita, Paolini, Annamaria, Borella, Rebecca, Mattioli, Marco, Fidanza, Lucia, Quong, Andrew, Petes, Carlene, Awong, Geneve, Douglas, Samuel, Lin, Dongxia, Nieto, Jordan, Gozzi, Licia, Franceschini, Erica, Busani, Stefano, Nasi, Milena, Mattioli, Anna Vittoria, Trenti, Tommaso, Meschiari, Marianna, Guaraldi, Giovanni, Girardis, Massimo, Mussini, Cristina, Gibellini, Lara, Cossarizza, Andrea, De Biasi, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9203559/ https://www.ncbi.nlm.nih.gov/pubmed/35710943 http://dx.doi.org/10.1038/s42003-022-03537-z

Ejemplares similares

Plasma Cytokine Atlas Reveals the Importance of TH2 Polarization and Interferons in Predicting COVID-19 Severity and Survival
por: Gibellini, Lara, et al.
Publicado: (2022)

Patients Recovering from Severe COVID-19 Develop a Polyfunctional Antigen-Specific CD4+ T Cell Response
por: Paolini, Annamaria, et al.
Publicado: (2022)

Author Correction: Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
por: De Biasi, Sara, et al.
Publicado: (2021)

Endogenous control of inflammation characterizes pregnant women with asymptomatic or paucisymptomatic SARS-CoV-2 infection
por: De Biasi, Sara, et al.
Publicado: (2021)

Prognostic immune markers identifying patients with severe COVID-19 who respond to tocilizumab
por: De Biasi, Sara, et al.
Publicado: (2023)

Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
por: Lo Tartaro, Domenico, et al.
Publicado: (2023)

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID‐19 pneumonia
por: Gibellini, Lara, et al.
Publicado: (2020)

Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
por: De Biasi, Sara, et al.
Publicado: (2020)

Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19
por: Paolini, Annamaria, et al.
Publicado: (2021)

A Comprehensive Analysis of Cytokine Network in Centenarians
por: Pinti, Marcello, et al.
Publicado: (2023)

Evaluating immunological and inflammatory changes of treatment-experienced people living with HIV switching from first-line triple cART regimens to DTG/3TC vs. B/F/TAF: the DEBATE trial
por: Cossarizza, Andrea, et al.
Publicado: (2023)

Increased Plasma Levels of Mitochondrial DNA and Normal Inflammasome Gene Expression in Monocytes Characterize Patients With Septic Shock Due to Multidrug Resistant Bacteria
por: Busani, Stefano, et al.
Publicado: (2020)

Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients
por: Riva, Giovanni, et al.
Publicado: (2021)

Reliable and Accurate CD4+ T Cell Count and Percent by the Portable Flow Cytometer CyFlow MiniPOC and “CD4 Easy Count Kit-Dry”, as Revealed by the Comparison with the Gold Standard Dual Platform Technology
por: Nasi, Milena, et al.
Publicado: (2015)

T Cell Activation but Not Polyfunctionality after Primary HIV Infection Predicts Control of Viral Load and Length of the Time without Therapy
por: Cossarizza, Andrea, et al.
Publicado: (2012)

Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids
por: Borella, Rebecca, et al.
Publicado: (2019)

Critical COVID-19 patients through first, second, and third wave: retrospective observational study comparing outcomes in intensive care unit
por: Coloretti, Irene, et al.
Publicado: (2023)

Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality
por: Gatto, Ilenia, et al.
Publicado: (2022)

Evidence for mitochondrial Lonp1 expression in the nucleus
por: Gibellini, Lara, et al.
Publicado: (2022)

Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study
por: Mussini, Cristina, et al.
Publicado: (2023)

Impaired Mitochondrial Morphology and Functionality in Lonp1(wt/−) Mice
por: De Gaetano, Anna, et al.
Publicado: (2020)

Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia
por: Busani, Stefano, et al.
Publicado: (2020)

Innate immunity changes in soccer players after whole-body cryotherapy
por: Selleri, Valentina, et al.
Publicado: (2022)

Redistribution of CD8+ T cell subsets in metastatic renal cell carcinoma patients treated with anti‐PD‐1 therapy
por: De Biasi, Sara, et al.
Publicado: (2022)

The Association of Procalcitonin and C-Reactive Protein with Bacterial Infections Acquired during Intensive Care Unit Stay in COVID-19 Critically Ill Patients
por: Campani, Simone, et al.
Publicado: (2023)

Natural Compounds Modulating Mitochondrial Functions
por: Gibellini, Lara, et al.
Publicado: (2015)

Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study
por: Coloretti, Irene, et al.
Publicado: (2021)

First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy
por: Meschiari, Marianna, et al.
Publicado: (2022)

Interfering with ROS Metabolism in Cancer Cells: The Potential Role of Quercetin
por: Gibellini, Lara, et al.
Publicado: (2010)

The impact of tocilizumab on respiratory support states transition and clinical outcomes in COVID-19 patients. A Markov model multi-state study
por: Milic, Jovana, et al.
Publicado: (2021)

Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
por: Gibellini, Lara, et al.
Publicado: (2020)

Dysfunctional subsets of CD39+ T cells, distinct from PD-1+, driven by leukemic extracellular vesicles in myeloid leukemias
por: Swatler, Julian, et al.
Publicado: (2022)

Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator
por: Mussini, Cristina, et al.
Publicado: (2021)

Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions
por: Gibellini, Lara, et al.
Publicado: (2023)

Association between Pulmonary Aspergillosis and Cytomegalovirus Reactivation in Critically Ill COVID-19 Patients: A Prospective Observational Cohort Study
por: Caciagli, Valeria, et al.
Publicado: (2023)

Adjunctive Immunotherapy With Polyclonal Ig-M Enriched Immunoglobulins for Septic Shock: From Bench to Bedside. The Rationale for a Personalized Treatment Protocol
por: Busani, Stefano, et al.
Publicado: (2021)

Anti-TNF-α Drugs Differently Affect the TNFα-sTNFR System and Monocyte Subsets in Patients with Psoriasis
por: Gibellini, Lara, et al.
Publicado: (2016)

Role of Selective Digestive Decontamination in the Prevention of Ventilator-Associated Pneumonia in COVID-19 Patients: A Pre-Post Observational Study
por: Biagioni, Emanuela, et al.
Publicado: (2023)

Effective Treatment of Patients Experiencing Primary, Acute HIV Infection Decreases Exhausted/Activated CD4+ T Cells and CD8+ T Memory Stem Cells
por: Lo Tartaro, Domenico, et al.
Publicado: (2022)

Quercetin and Cancer Chemoprevention
por: Gibellini, Lara, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_45ie6o5lfujamnmp8j2bembvl3